APAC's IVD market post-pandemic recovery & outlook

Asia-Pacific’s IVD market: post-pandemic recovery trends and the future outlook

Over the past two years, the global in-vitro diagnostics (IVD) sector has experienced various shifts and developments. The pandemic’s far-reaching impact across economies and healthcare systems has affected everything from IVD testing trends, to laboratory capacities. As covid-19 becomes endemic, IVD companies are reassessing their priorities based on future growth opportunities and challenges.

This paper examines the Asia-Pacific (APAC) region where the virus first emerged, across the timeline from 2019 to 2021 in 16 markets, to find out if the IVD market has fully rebounded from the disruption of covid-19. Understand recovery and growth trends in key segments, from centralised diagnostics (CEDx) and molecular diagnostics (MDx), to point-of-care testing.

Download free report

Clearstate newsletter

The latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate's newsletter today.